Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. Founded in 2017, Alloy Therapeutics is headquartered in Lexington, Massachusetts.
Alpha Tau Medical is an Israeli medical device company that focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Since then, numerous preclinical trials have found the technology to be effective and safe for various indications and anatomic areas. The findings were published in 12 papers in peer-reviewed scientific journals. Today, the company is running its first clinical trial with very promising preliminary results.
Arcadia is a climate technology company enabling a zero-carbon economy. By unlocking high-fidelity, global energy data for the first time, the Arc platform combines easy-to-use data and APIs under one roof to allow any company to act on its environmental impact and build the next generation of energy products and climate tech solutions. Arc democratizes access to data from thousands of utility providers in over 50 countries, covering more than 95% of US utility accounts. Founded in 2014 on the belief that everyone deserves access to clean energy, Arcadia also manages the nation’s leading community solar program, helping to tackle energy injustice while spurring economic growth with more than 2 GW of solar under management.
Astra is a rocket launch startup that provides satellite delivery service and launch service. It offers online reservations for payload deliveries to both sun-synchronous and low inclination orbits. Astra also offers dedicated launch services of 50kg-150kg payloads to 500km SSO reference orbit in 2020 and 2021. The company was founded in 2016 by Chris Kemp and Adam with a mission to provide daily access to space.
BioCatch is the leader in Behavioral Biometrics which analyzes an online user’s physical and cognitive digital behavior to protect individuals and their assets. Our mission is to unlock the power of behavior and deliver actionable insights to create a digital world where identity, trust and ease seamlessly co-exist. Leading financial institutions around the globe use BioCatch to more effectively fight fraud, drive digital transformation and accelerate business growth. With over a decade of analyzing data, over 60 patents and unparalleled experience, BioCatch continues to innovate to solve tomorrow’s problems. For more information, please visit www.biocatch.com
Powered by AI, Biolojic is a leading edge company that designs single or multi-specific human antibodies for predefined epitopes. They call these fully human antibodies Multibodies. This creates a significant advantage when trying to bind more than one target with the same mAb or when trying to affect difficult and complex targets.
Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality. By creating a new medical modality of remote-controlled micro-robots called Bionauts, the company can transform the way the biopharmaceutical industry develops treatments, allowing them to engineer the therapeutic index for efficacy and maintain safety. Bionaut Labs is focused on helping patients suffering from debilitating brain diseases who have few available treatment options. The anatomical targeting capabilities of the Bionaut platform make new therapeutics technologies such as gene therapy, CRISPR-Cas9, and oncolytic viruses viable in challenging clinical settings.